fda bpc-157 warning not approved peptide In July 2026, an advisory committee voted to add six of seven peptides to a drug compounding list. Although the vote does mean FDA approval, the recommendation brings these popular bpc-157 fda approved warning not

guidance for repeated-entry vials points to a 28-day window unless the label states another period, and that opened-vial window cannot go past the original expiration date

Reconstitution for different vial sizes GHK-Cu comes in various vial sizes, most commonly 50mg and 100mg

In a research setting, this means a single vial can be accessed multiple times over days or weeks without significant risk of contamination a distinct advantage when working with multi-dose peptide preparations

Lyophilized (Long-term) -20C (-4F) Freezer

For regulation compliance, if you need pharmaceutical-grade uniformity, SLU-PP-332 is the most reliable option